Trial Details
COMPLETEDBasic Information
| Clinical ID | c1471 |
|---|---|
| Identifier | NCT02136069 |
| Trial Title | A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Nave to Tumor Necrosis Factor (TNF) Inhibitors |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Etrolizumab|DRUG: Infliximab|OTHER: Placebo (IV)|OTHER: Placebo (Injection) |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Salzburg |
| Country/Region | Austria |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-12-24 |
|---|---|
| Primary Completion Date | 2020-06-23 |
| Completion Date | 2020-06-23 |